Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Aminopterin in Treating Patients With Refractory Leukemia

ClinicalTrials.gov ID: NCT00003305

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00003305. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 22, 2026, 4:02 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Trial of Aminopterin in Adults and Children With Refractory Acute Leukemia Grant Application Title: A Phase II Trial of Aminopterin in Acute Leukemia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of aminopterin in treating patients who have refractory leukemia.

Study identification

NCT ID
NCT00003305
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Genzyme, a Sanofi Company
Industry
Enrollment
75 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 1997 (Type not available)
Primary completion
Not listed
Completion
Sep 2007 (Actual)
Last update posted
Jan 6, 2014

1997 – 2007

United States locations

U.S. sites
14
U.S. states
9
U.S. cities
13
Facility City State ZIP Site status
Advanced Urology Medical Center Anaheim California 92801 —
South Coast Urological Medical Group Laguana Hills California 92653 —
Urology Specialists, P.C. Waterbury Connecticut 06708 —
Barzell, Whitmore, Treiman and Dunne - The Urology Treatment Center Sarasota Florida 34239 —
University of Chicago Cancer Research Center Chicago Illinois 60637 —
206 Research Associates Greenbelt Maryland 20770 —
Mid Atlantic Clinical Research Rockville Maryland 20850 —
Cancer Institute of New Jersey New Brunswick New Jersey 08901 —
Medical & Clinical Research Associates, LLC Bay Shore New York 11706 —
Herbert Irving Comprehensive Cancer Center New York New York 10032 —
Medical City Dallas Hospital Dallas Texas 75230 —
Urology Centers of North Texas Dallas Texas 75231 —
Urology San Antonio Research San Antonio Texas 78229 —
Children's Hospital and Regional Medical Center - Seattle Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00003305, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 6, 2014 · Synced Nov 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.